Arachidonic acid 5-hydroperoxide
![]() | |
Names | |
---|---|
Preferred IUPAC name
(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoic acid | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider | |
IUPHAR/BPS
|
|
MeSH | Arachidonic+acid+5-hydroperoxide |
PubChem CID
|
|
| |
| |
Properties | |
C20H32O4 | |
Molar mass | 336.466 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
![]() ![]() ![]() | |
Infobox references | |
Arachidonic acid 5-hydroperoxide (5-hydroperoxyeicosatetraenoic acid, 5-HPETE) is an intermediate in the metabolism of arachidonic acid by the ALOX5 enzyme in humans or Alox5 enzyme in other mammals. The intermediate is then further metabolized to: a) leukotriene A4 which is then metabolized to the chemotactic factor for leukocytes, leukotriene B4, or to contractors of lung airways, leukotriene C4, leukotriene D4, and leukotriene E4; b) the leukocyte chemotactic factors, 5-Hydroxyicosatetraenoic acid and 5-oxo-eicosatetraenoic acid; or c) the specialized pro-resolving mediators of inflammation, lipoxin A4 and lipoxin B4.[1][2]
![](http://upload.wikimedia.org/wikipedia/commons/thumb/4/40/Eicosanoid_synthesis.svg/320px-Eicosanoid_synthesis.svg.png)
Eicosanoid synthesis.
References[]
- ^ Haeggström JZ, Funk CD (2011). "Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease". Chemical Reviews. 111 (10): 5866–98. doi:10.1021/cr200246d. PMID 21936577.
- ^ Romano M, Cianci E, Simiele F, Recchiuti A (2015). "Lipoxins and aspirin-triggered lipoxins in resolution of inflammation". European Journal of Pharmacology. 760: 49–63. doi:10.1016/j.ejphar.2015.03.083. PMID 25895638.
Categories:
- Organic peroxides
- Biochemistry
- Eicosanoids
- Fatty acids
- Alkene stubs
- Biochemistry stubs